Patents by Inventor Larry D. Zeagler

Larry D. Zeagler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5399707
    Abstract: A process is provided whereby S(+)-ibuprofen or R(-)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of one of the enantiomers in the ibuprofen enantiomeric mixture. Upon precipitation of one ibuprofen enantiomer from the mixture, the overall precipitate and reaction mixture can be held for a sufficient period of time at a second temperature to allow the first precipitate to redissolve into the reaction mixture and the other ibuprofen enantiomer to precipitate out of the mixture in the salt form. Optically active ibuprofen is racemized by being heated at 100.degree. C. to 300.degree. C. in the substantial absence of other materials.
    Type: Grant
    Filed: June 10, 1994
    Date of Patent: March 21, 1995
    Assignee: Hoechst Celanese Corporation
    Inventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina A. McAdams
  • Patent number: 5380867
    Abstract: A process is provided whereby S(+)-ibuprofen or R(-)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of one of the enantiomers in the ibuprofen enantiomeric mixture. Upon precipitation of one ibuprofen enantiomer from the mixture, the overall precipitate and reaction mixture can be held for a sufficient period of time at a second temperature to allow the first precipitate to redissolve into the reaction mixture and the other ibuprofen enantiomer to precipitate out of the mixture in the salt form. Optically active ibuprofen is racemized by being heated at 100.degree. C. to 300.degree. C. in the substantial absence of other materials.
    Type: Grant
    Filed: October 19, 1993
    Date of Patent: January 10, 1995
    Assignee: Hoechst Celanese Corporation
    Inventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina A. McAdams
  • Patent number: 5332834
    Abstract: There is disclosed and claimed a process whereby S(+)-ibuprofen L-lysinate salt is produced by selective precipitation from a mixture containing enantiomers of ibuprofen and L-lysine. The quantity of L-lysine is not more than about a molar equivalent of the quantity of S(+)-ibuprofen in the ibuprofen enantiomeric mixture. The mother liquors after separating the above salt are enriched in R-ibuprofen which is racemized by a novel thermal racemization process and may then be recycled.
    Type: Grant
    Filed: December 2, 1992
    Date of Patent: July 26, 1994
    Assignee: Hoechst Celanese Corporation
    Inventors: Apurba Bhattacharya, John R. Fritch, Carl D. Murphy, Larry D. Zeagler, Carina Araullo-McAdams
  • Patent number: 4329511
    Abstract: In hydroformylating an olefinic compound to produce an aldehyde derivative thereof employing as catalyst a complex of a Group VIII metal and an organic ligand dissolved in an inert liquid reaction solvent with the aldehyde product being continuously stripped out of the solvent, stripping is facilitated while by-product formation is kept at a minimum by using a solvent of specially-chosen high molecular weight while also controlling the degree of stripping as desired to maintain in the reaction medium a controlled molar concentration of the aldehyde hydroformylation product.
    Type: Grant
    Filed: June 23, 1980
    Date of Patent: May 11, 1982
    Assignee: Celanese Corporation
    Inventors: Edward B. Hackman, Larry D. Zeagler, James S. McLaughlin, Carl M. Peabody